PhySH "Physician Scientist Hour"

INDE 217 : Physician Scientist Hour (PhySH)
Mondays at 12:30pm - 1:20pm

Due to the COVID-19 pandemic, PhySH will be virtual for Autumn 2020 (via Zoom). We will provide updates for subsequent quarters as information becomes available.

Please register for PhySH - INDE 217
(You are not required to register to attend.)

You might also be interested in the TRAM lecture series, which hosts speakers who are recognized leaders in translational research and applied medicine.  Please see the Translational Research and Applied Medicine website for more information.

Winter 2021 PhySH Schedule

(We will provide updates as information becomes available) .

G2 Presentations: Vipul Vachharajani; Andrea Garofalo
January 11, 2021

Vipul Vachharajani
Single-molecule force spectroscopy of epithelial cell adhesion molecules
Lab of Alex Dunn, PhD
Program in Biophysics

Andrea Garofalo
Deep sequencing of cell-free DNA for noninvasive detection of immunosuppression-related lymphoid malignancies
Lab of Ash Alizadeh, MD, PhD
Program in Cancer Biology

Elen Yeh
January 25, 2021

G2 Presentation: Alvaro Amorin; David Wang
February 1, 2021

Alvaro Amorin
Dual stem cell therapy for Krabbe disease
Lab of Natalia Gomez Ospina, MD, PhD
Program in Stem Cell Biology & Regenerative Medicine

David Wang
The role of neuronal activity in building brain circuits
Lab of Liqun Luo, PhD
Department of Biology

Katrin Svensson
February 8, 2021

Suchita Rastogi
February 22, 2021
Disabilities

Paul George
March 1, 2021

Catherine Blish
March 8, 2021
Grant Writing: F30
Dr. Blish's research is on infectious diseases.  She is a Chan Zuckerberg BioHub Investigator and is an Associate Director of the Stanford MSTP program.

Autumn 2020 PhySH Schedule

Electron Kebebew
September 14,  2020
What to investigate and why?
Dr. Kebebew is the Harry A. Oberhelman, Jr and Mark L. Welton Professor of Surgery and is Chief of the Division of General Surgery & Lab Director at Stanford. Dr. Kebebew’s translational and clinical investigations have three main scientific goals: 1) to develop effective therapies for fatal, rare and neglected endocrine cancers, 2) to identify new methods, strategies and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognostication of endocrine cancers, and 3) to develop methods for precision treatment of endocrine tumors.

G2 Presentation: Maria Filsinger Interrante
September 21, 2020
Targeting the prehairpin intermediate of HIV-1 fusion towards development of a prophylactic vaccine
Lab of Peter Kim, PhD
Program in Biophysics

Taia Wang
October 5, 2020
Reflections and Q&A on my physician-scientist training path and transition to a faculty position
Dr. Wang’s research is aimed at defining mechanisms in human immunity and disease. The Wang laboratory uses in vivo and in vitro systems to study how antibodies can modulate viral infections or anti-viral vaccine responses through signaling interactions with Fc gamma receptors (FcγRs). The overarching goal of projects in the Wang lab is to elucidate FcγR pathways that can be harnessed towards the development of enhanced vaccines and therapeutics.

G2 Presentations: Ved Topkar; Kathryn Wu
October 12, 2020

Ved Topkar
Structural characterization of mRNA transport in oligodendrocytes
Lab of Rhiju Das, PhD
Program in Biophysics

Kathryn Wu
How Schwann cells sort and myelinate axons
Lab of Brad Zuchero, PhD
Program in Neurosciences

Steve Goodman #1
October 19, 2020
Research reproducibility - Definitions and  practice of “rigor and reproducibility” in  proposals and in lab and clinical research
Dr. Goodman's research concerns the proper measurement, conceptualization and synthesis of research evidence, with particular emphasis on Bayesian approaches to quantitation, and qualitative approaches arising from the philosophy of science. He is also interested in developing methods to use shared data to confirm and extend published science, as well as to explore new hypotheses. He also has worked on the connections between ethics and scientific methods, particularly in the domain of interventional research, and policy making.

G2 Presentations: Angela Zhang; Shivam Verma
October 26, 2020

Angela Zhang
Developing Label Free Methods to Characterize Induced Pluripotent Stem Cell Derived Cardiomyocytes
Labs of Joseph Wu, MD, PhD, and Russ Altman, MD, PhD
Program in Biomedical Informatics

Shivam Verma
Templated production of single-stranded DNA in mammalian cells
Lab of  Carolyn Bertozzi, PhD
Department of Chemical and Systems Biology

Tom Rando
November 2, 2020
The journey of a physician scientist: Random walks and infinite sample space
Dr. Rando's research focuses on tissue-specific stem cells in aging and disease, and on pathogenetic mechanisms and gene therapy for muscular dystrophies. His research on aging has demonstrated that it is possible to identify biochemical stimuli that can induce stem cells in old tissues to repair injuries as effectively as in young tissues, and this work has broad implications for the fields of regenerative medicine and stem cell transplantation.

G2 Presentations: Aaron WIlk; Tim Chai
November 9, 2020

Aaron Wilk
Seq-ing answers to COVID-19: Lessons from multimodal immune profiling
Lab of Catherine Blish, MD, PhD
Program in Immunology

Tim Chai
How T cells communicate with cancer cells
Lab of Irving Weissman, MD
Program in Cancer Biology

MSTP Diversity Working Group (DWG)
November 16, 20200
DWG's structure and goals for the upcoming year
The mission of the MSTP Diversity Working Group (DWG) is to promote and support diversity of all kinds, at all phases of the physician scientist training process, by fostering and advocating for the equal treatment of all prospective and current MSTP students in recruitment, admission, retention and career placement of MSTP students. 

Steve Goodman #2
November 30, 2020
Design, data analysis and data management
Dr. Goodman's research concerns the proper measurement, conceptualization and synthesis of research evidence, with particular emphasis on Bayesian approaches to quantitation, and qualitative approaches arising from the philosophy of science. He is also interested in developing methods to use shared data to confirm and extend published science, as well as to explore new hypotheses. He also has worked on the connections between ethics and scientific methods, particularly in the domain of interventional research, and policy making.